Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

[Using resource groups in assertive community treatment; literature review and recommendation].

Smeerdijk M, Delespaul PHAEG, Keet IPM, Nugter MA.

Tijdschr Psychiatr. 2017;59(8):466-473. Review. Dutch.

2.

[Functional remission of people with serious mental illness (SMI): psychometric properties of a new ROM-instrument].

Wiersma D, Visser E, Bähler M, Bruggeman R, Delespaul PA, van der Gaag M, de Haan L, Keet IP, Nijssen Y, van Os J, Pijnenborg GH, Slooff C, Swildens W, de Vos AE, van Weeghel J, Wunderink L, Mulder CL.

Tijdschr Psychiatr. 2015;57(6):395-404. Dutch.

3.

[Come across to improve the treatment of severe metal illness].

Keet IP.

Tijdschr Psychiatr. 2014;56(11):706-7. Dutch. No abstract available.

4.

[The last book issue].

Keet IP, Dom G.

Tijdschr Psychiatr. 2013;55(12):924. Dutch. No abstract available.

5.

[Recovery].

Keet IP.

Tijdschr Psychiatr. 2013;55(12):921-3. Dutch. No abstract available.

6.

[ROM: primarily an instrument for treat].

Keet IP, Nugter MA, Hafkenscheid A, Van Den Eede F, Thunnissen MM.

Tijdschr Psychiatr. 2012;54(2):107-9. Dutch. No abstract available.

7.

[Getting better at home, not in the hospital].

Keet IP.

Tijdschr Psychiatr. 2011;53(10):691-3. Dutch. No abstract available.

8.

Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST).

Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW, Keefe RS, Boter H, Keet IP, Prelipceanu D, Rybakowski JK, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors N, Riecher-Rössler A, Kahn RS.

Am J Psychiatry. 2009 Jun;166(6):675-82. doi: 10.1176/appi.ajp.2008.08060806. Epub 2009 Apr 15. Erratum in: Am J Psychiatry. 2009 Jun;166(6):731.

PMID:
19369319
9.

[Severe mental illness: cure and care?].

Keet IP.

Tijdschr Psychiatr. 2008;50(9):555-7. Dutch. No abstract available.

10.

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.

Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, Gheorghe MD, Rybakowski JK, Galderisi S, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors N, Riecher-Rössler A, Grobbee DE; EUFEST study group.

Lancet. 2008 Mar 29;371(9618):1085-97. doi: 10.1016/S0140-6736(08)60486-9.

PMID:
18374841
11.

[Delirium on re-starting clozapine after a short break in treatment].

Benckhuijsen JA, Keet IP.

Tijdschr Psychiatr. 2007;49(9):661-5. Dutch.

12.

The European First Episode Schizophrenia Trial (EUFEST): rationale and design of the trial.

Fleischhacker WW, Keet IP, Kahn RS; EUFEST Steering Committee.

Schizophr Res. 2005 Oct 15;78(2-3):147-56.

PMID:
16055308
13.

[Lithium, a potentially dangerous drug].

van der Goot B, Hagen EC, Keet IP, Wernand J.

Ned Tijdschr Geneeskd. 2005 Apr 30;149(18):1018; author reply 1018-9. Dutch. No abstract available.

PMID:
15903048
14.

Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type 1 infection is predictive of persistent AIDS-free infection.

Pontesilli O, Carotenuto P, Kerkhof-Garde SR, Roos MT, Keet IP, Coutinho RA, Goudsmit J, Miedema F.

AIDS Res Hum Retroviruses. 1999 Jul 20;15(11):973-81.

PMID:
10445809
15.

Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men.

Keet IP, Tang J, Klein MR, LeBlanc S, Enger C, Rivers C, Apple RJ, Mann D, Goedert JJ, Miedema F, Kaslow RA.

J Infect Dis. 1999 Aug;180(2):299-309.

PMID:
10395843
16.

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine.

Foudraine NA, Hoetelmans RM, Lange JM, de Wolf F, van Benthem BH, Maas JJ, Keet IP, Portegies P.

Lancet. 1998 May 23;351(9115):1547-51.

PMID:
10326538
17.

HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection.

Tang J, Costello C, Keet IP, Rivers C, Leblanc S, Karita E, Allen S, Kaslow RA.

AIDS Res Hum Retroviruses. 1999 Mar 1;15(4):317-24.

PMID:
10082114
18.

Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis.

Koot M, van Leeuwen R, de Goede RE, Keet IP, Danner S, Eeftinck Schattenkerk JK, Reiss P, Tersmette M, Lange JM, Schuitemaker H.

J Infect Dis. 1999 Jan;179(1):254-8.

PMID:
9841850
19.

In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type 1 infection is associated with T cell nonresponsiveness in vitro.

Maas JJ, Roos MT, Keet IP, Mensen EA, Krol A, Veenstra J, Schellekens PT, Jurriaans S, Coutinho RA, Miedema F.

J Infect Dis. 1998 Oct;178(4):1024-9.

PMID:
9806030
20.

Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS.

Maas JJ, Dukers N, Krol A, van Ameijden EJ, van Leeuwen R, Roos MT, de Wolf F, Coutinho RA, Keet IP.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Nov 1;19(3):254-9.

PMID:
9803967
21.

An open randomized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudine.

Foudraine NA, de Jong JJ, Jan Weverling G, van Benthem BH, Maas J, Keet IP, Jurriaans S, Roos MT, Vandermeulen K, de Wolf F, Lange JM.

AIDS. 1998 Aug 20;12(12):1513-9.

PMID:
9727573
22.

[HIV infection and risky sexual behavior in a new cohort of young homosexual men in Amsterdam, 1995-1996].

van Griensven GJ, van den Bergh HS, Jansen M, de Wit JB, Keet IP.

Ned Tijdschr Geneeskd. 1997 Nov 22;141(47):2293-6. Dutch.

PMID:
9550814
23.

Association between CCR5 genotype and the clinical course of HIV-1 infection.

de Roda Husman AM, Koot M, Cornelissen M, Keet IP, Brouwer M, Broersen SM, Bakker M, Roos MT, Prins M, de Wolf F, Coutinho RA, Miedema F, Goudsmit J, Schuitemaker H.

Ann Intern Med. 1997 Nov 15;127(10):882-90.

PMID:
9382366
24.

Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type 1 RNA levels in persons remaining AIDS-free despite CD4 cell counts <200 for >5 years.

Keet IP, Janssen M, Veugelers PJ, Miedema F, Klein MR, Goudsmit J, Coutinho RA, de Wolf F.

J Infect Dis. 1997 Sep;176(3):665-71.

PMID:
9291313
25.

Incidence and prognostic significance of symptomatic primary human immunodeficiency virus type 1 infection in homosexual men.

Veugelers PJ, Kaldor JM, Strathdee SA, Page-Shafer KA, Schechter MT, Coutinho RA, Keet IP, van Griensven GJ.

J Infect Dis. 1997 Jul;176(1):112-7.

PMID:
9207356
26.

Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis.

Veenstra J, Veugelers PJ, Keet IP, van der Ven AJ, Miedema F, Lange JM, Coutinho RA.

Clin Infect Dis. 1997 May;24(5):936-41.

PMID:
9142796
27.

Polymorphisms within the human tumor necrosis factor-alpha promoter region in human immunodeficiency virus type 1-seropositive persons.

Brinkman BM, Keet IP, Miedema F, Verweij CL, Klein MR.

J Infect Dis. 1997 Jan;175(1):188-90.

PMID:
8985218
28.

Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993.

Keet IP, Veugelers PJ, Koot M, de Weerd MH, Roos MT, Miedema F, de Wolf F, Goudsmit J, Coutinho RA.

AIDS. 1996 Nov;10(13):1601-2. No abstract available.

PMID:
8931802
29.

Differences in progression to AIDS between injection drug users and homosexual men with documented dates of seroconversion.

Spijkerman IJ, Langendam MW, Veugelers PJ, van Ameijden EJ, Keet IP, Geskus RB, van den Hoek A, Coutinho RA.

Epidemiology. 1996 Nov;7(6):571-7.

PMID:
8899381
30.

Single cell analysis of IL-4 and IFN-gamma production by T cells from HIV-infected individuals: decreased IFN-gamma in the presence of preserved IL-4 production.

Meyaard L, Hovenkamp E, Keet IP, Hooibrink B, de Jong IH, Otto SA, Miedema F.

J Immunol. 1996 Sep 15;157(6):2712-8.

PMID:
8805678
31.

[HIV incidence in a cohort of homosexual men and a cohort of injecting drug users in Amsterdam, 1985-1995].

van den Hoek JA, van Griensven GJ, Keet IP, Coutinho RA.

Ned Tijdschr Geneeskd. 1996 Aug 17;140(33):1692-5. Dutch.

PMID:
8830294
32.

The role of host genetics in the natural history of HIV-1 infection: the needles in the haystack.

Keet IP, Klein MR, Just JJ, Kaslow RA.

AIDS. 1996;10 Suppl A:S59-67. Review. No abstract available.

PMID:
8883611
33.

Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men.

Spijkerman IJ, Koot M, Prins M, Keet IP, van den Hoek AJ, Miedema F, Coutinho RA.

AIDS. 1995 Sep;9(9):1085-92.

PMID:
8527083
34.

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.

Klein MR, van Baalen CA, Holwerda AM, Kerkhof Garde SR, Bende RJ, Keet IP, Eeftinck-Schattenkerk JK, Osterhaus AD, Schuitemaker H, Miedema F.

J Exp Med. 1995 Apr 1;181(4):1365-72.

35.

Changes in cytokine secretion patterns of CD4+ T-cell clones in human immunodeficiency virus infection.

Meyaard L, Otto SA, Keet IP, van Lier RA, Miedema F.

Blood. 1994 Dec 15;84(12):4262-8.

36.

Predictors of disease progression in HIV-infected homosexual men with CD4+ cells < 200 x 10(6)/l but free of AIDS-defining clinical disease.

Keet IP, Krol A, Koot M, Roos MT, de Wolf F, Miedema F, Coutinho RA.

AIDS. 1994 Nov;8(11):1577-83.

PMID:
7848594
37.

Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men.

Klein MR, Keet IP, D'Amaro J, Bende RJ, Hekman A, Mesman B, Koot M, de Waal LP, Coutinho RA, Miedema F.

J Infect Dis. 1994 Jun;169(6):1244-9.

PMID:
8195600
38.

Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts.

Keet IP, Krol A, Klein MR, Veugelers P, de Wit J, Roos M, Koot M, Goudsmit J, Miedema F, Coutinho RA.

J Infect Dis. 1994 Jun;169(6):1236-43.

PMID:
7910835
39.

Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease.

Meyaard L, Otto SA, Keet IP, Roos MT, Miedema F.

J Clin Invest. 1994 Mar;93(3):982-8.

40.

[HIV infection and unsafe sexual behavior among young homosexual men in Amsterdam, 1992].

Keet IP, van den Bergh HS, van Griensven GJ, Coutinho RA, Sandfort TG, van den Hoek JA.

Ned Tijdschr Geneeskd. 1993 Dec 25;137(52):2709-12. Dutch.

PMID:
8289943
41.

Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.

Koot M, Keet IP, Vos AH, de Goede RE, Roos MT, Coutinho RA, Miedema F, Schellekens PT, Tersmette M.

Ann Intern Med. 1993 May 1;118(9):681-8.

PMID:
8096374
42.

Predictors of rapid progression to AIDS in HIV-1 seroconverters.

Keet IP, Krijnen P, Koot M, Lange JM, Miedema F, Goudsmit J, Coutinho RA.

AIDS. 1993 Jan;7(1):51-7.

PMID:
8095146
43.

Insufficient response to hepatitis B vaccination in HIV-positive homosexual men.

Keet IP, van Doornum G, Safary A, Coutinho RA.

AIDS. 1992 May;6(5):509-10. No abstract available.

PMID:
1535502
44.

Orogenital sex and the transmission of HIV among homosexual men.

Keet IP, Albrecht van Lent N, Sandfort TG, Coutinho RA, van Griensven GJ.

AIDS. 1992 Feb;6(2):223-6.

PMID:
1558719
45.

Herpes simplex virus type 2 and other genital ulcerative infections as a risk factor for HIV-1 acquisition.

Keet IP, Lee FK, van Griensven GJ, Lange JM, Nahmias A, Coutinho RA.

Genitourin Med. 1990 Oct;66(5):330-3.

Supplemental Content

Support Center